This study assessed the effect of public health advisories issued between 2005 and 2007 by the U.S. Food and Drug Administration (FDA) on treatments of attention-deficit hyperactivity disorder (ADHD) and physician prescribing practices
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
Last week, two separate advisory committees of the Food and Drug Administration assembled in the sub...
Medication for the treatment of attention-deficit hyperactivity disorder (ADHD) is in widespread use...
This study assessed the effect of public health advisories issued between 2005 and 2007 by the U.S. ...
Background. Since the Food and Drug Administration (FDA) released a warning with regards to potentia...
Background: Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacother...
Attention deficit hyperactivity disorder (ADHD), the most common behavioral disorder in children, ma...
Attention deficit hyperactivity disorder, more commonly known as ADHD, is highly prevalent in child...
ObjectiveDescribe the parent-reported prevalence of ADHD treatments among a national sample of child...
Objectives: Because of several recent clinical and regulatory changes regarding Attention Deficit Hy...
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemp...
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with onset usually ...
On May 3, 2016, this report was posted online as an MMWR Early Release.BACKGROUND: Attention deficit...
Eleven percent of American children are diagnosed with at least one type of ADHD. That is 6.4 millio...
Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and adults, with...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
Last week, two separate advisory committees of the Food and Drug Administration assembled in the sub...
Medication for the treatment of attention-deficit hyperactivity disorder (ADHD) is in widespread use...
This study assessed the effect of public health advisories issued between 2005 and 2007 by the U.S. ...
Background. Since the Food and Drug Administration (FDA) released a warning with regards to potentia...
Background: Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacother...
Attention deficit hyperactivity disorder (ADHD), the most common behavioral disorder in children, ma...
Attention deficit hyperactivity disorder, more commonly known as ADHD, is highly prevalent in child...
ObjectiveDescribe the parent-reported prevalence of ADHD treatments among a national sample of child...
Objectives: Because of several recent clinical and regulatory changes regarding Attention Deficit Hy...
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemp...
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with onset usually ...
On May 3, 2016, this report was posted online as an MMWR Early Release.BACKGROUND: Attention deficit...
Eleven percent of American children are diagnosed with at least one type of ADHD. That is 6.4 millio...
Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and adults, with...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
Last week, two separate advisory committees of the Food and Drug Administration assembled in the sub...
Medication for the treatment of attention-deficit hyperactivity disorder (ADHD) is in widespread use...